KRAS and neoplasm: KRAS mutational status has been usually analyzed in tumor tissue, but obtaining biopsy specimens from pancreatic lesions may be difficult and requires invasive procedures, such as endoscopic ultrasound-guided fine needle aspiration (EUS-FNA).